Delivery Order SPE2DB25D7056-SPE2DB25FTMQC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,219.51 to AmerisourceBergen Drug Corp for the supply of Telmisartan 20 mg tablets (30-count packages) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $2,465.23 to AmerisourceBergen Drug Corp for the supply of Telmisartan 20 mg tablets (30-count units) under a firm fixed-price contract. The award was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Telmisartan 20 mg tablets (30-count) valued at $11,635.07. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. As a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,354.46 to AmerisourceBergen Drug Corp for the supply of Telmisartan 20 mg tablets (30-count) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price delivery order represents a non-competitive contract type issued without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,330.61 to AmerisourceBergen Drug Corp for the supply of Telmisartan 20 mg tablets (30-count units) on September 17, 2025, with completion expected by September 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,859.07 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on June 18, 2025, with completion scheduled for June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $5,918.34 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on September 19, 2025, with an ultimate completion date of September 22, 2025. This non-set-aside, firm fixed-price contract was awarded competitively and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,732.38 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Telmisartan 20 mg on September 25, 2025, with completion scheduled for September 26, 2025. This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 20 mg tablets (30-count) under a firm fixed-price contract valued at $1,049.92. This non-set-aside award was issued on October 15, 2025, with an ultimate completion date of October 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single line item drawn from a larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,258.98 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a single transaction under AmerisourceBergen's...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTMQCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,360.02 to AmerisourceBergen Drug Corp for the supply of Telmisartan 20 mg tablets (30-count units) on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a maximum value of $999,999,999.00 and extends through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The prime contract supports multiple federal customers, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 6/18/25 |